Exogenous TIMPs, such as fucoidan, maintain the ECM homeostasis by increasing TIMP-1 and decreasing MMP-2 and MMP-9 through downregulation of TGF-β signaling, implicitly decreasing the aggressiveness of HCC by preventing the EMT [103]. Here, MMP2 is linked to hepatocellular carcinoma.